Interestingly, heterozygous mutations of MYRF in humans lead to nanophthalmos [28–31], suggesting loss of this protein has the opposite effect to the activation we suggest occurs in the Tmem98 deletion eyes. The gene discussed is TMEM98; the disease is microphthalmia.